Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural changes in human pituitary tumor after bromocriptine therapy

S S Rengachary, T Tomita, B F Jefferies

    Neurosurgery
    |February 1, 1982
    PubMed
    Summary

    Bromocriptine therapy effectively reduced prolactin-producing tumors, causing reversible cellular changes. Growth hormone-secreting tumors showed no comparable response to this treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Effect of stimulus intensity on visual stream segregation].

    Shinrigaku kenkyu : The Japanese journal of psychology·1992
    Same author

    Resolution and some properties of enzymes involved in enantioselective transformation of 1,3-dichloro-2-propanol to (R)-3-chloro-1,2-propanediol by Corynebacterium sp. strain N-1074.

    Journal of bacteriology·1992
    Same author

    [A case of invasion of the hyaloid artery into the lens].

    Nippon Ganka Gakkai zasshi·1992
    Same author

    [A case of systemic lupus erythematosus complicated with monoclonal CD5 + B cell proliferation suspected as chronic lymphocytic leukemia].

    Ryumachi. [Rheumatism]·1992
    Same author

    [A case of nonobstructive hypertrophic cardiomyopathy associated with ventricular tachycardia and sick sinus syndrome].

    Kokyu to junkan. Respiration & circulation·1992
    Same author

    [Reticular degeneration of retinal pigment epithelium].

    Nippon Ganka Gakkai zasshi·1992

    Area of Science:

    • Endocrinology
    • Oncology
    • Cell Biology

    Background:

    • Prolactin-producing and growth hormone-producing tumors require effective therapeutic strategies.
    • Bromocriptine is a dopamine agonist used in treating pituitary tumors.

    Observation:

    • This study investigated the histological effects of short-term bromocriptine therapy on prolactinomas and growth hormone-secreting tumors.
    • Microscopic examination included light and electron microscopy, alongside immunocytochemistry.

    Findings:

    • Bromocriptine therapy induced significant histological changes in prolactinomas, including nuclear chromatin clumping and reduced cytoplasmic volume.
    • These structural alterations in prolactinomas correlated with normalized serum prolactin levels and decreased tumor size.
    • No comparable clinical, biochemical, radiological, or structural changes were observed in growth hormone-secreting tumors.

    Related Experiment Videos

    Implications:

    • The findings suggest bromocriptine induces a reversible inhibition of protein synthesis in prolactin-producing tumor cells.
    • This provides a cellular basis for bromocriptine's efficacy in treating prolactinomas.
    • The differential response highlights distinct cellular mechanisms in different pituitary tumor types.